MTHFR Gene Mutations Explained
MTHFR Gene Mutations
Two Key Variations
While many variations of the MTHFR gene exist, two specific single nucleotide polymorphisms, or SNPs, are the most studied. These are common genetic variations that can affect the enzyme's structure and function. They're like typos in the gene's instruction manual.
Polymorphism
noun
A variation in a DNA sequence that is common in a population. To be classified as a polymorphism, the variation must occur in at least 1% of the population.
The first key SNP is called C677T. This name is a shorthand for the specific change: at position 677 of the MTHFR gene, a cytosine (C) nucleotide is replaced by a thymine (T). This single switch changes the amino acid in the resulting enzyme from an alanine to a valine. The consequence is a less stable, less efficient enzyme. It becomes more sensitive to heat and has a reduced ability to function, especially when folate levels are low.
The C677T variant can reduce MTHFR enzyme activity by up to 70% in individuals who inherit the mutation from both parents (homozygous).
The second common SNP is A1298C. At position 1298, an adenine (A) is replaced by a cytosine (C). This results in a glutamate being swapped for an alanine in the enzyme. The A1298C mutation also reduces enzyme activity, but to a lesser degree than the C677T variant.
An individual can inherit one or both of these SNPs. Someone with one C677T and one A1298C mutation is known as a compound heterozygote. This combination also leads to a significant decrease in MTHFR enzyme function.
When there’s a mutation in the MTHFR gene, this conversion can be less efficient, leading to elevated homocysteine levels and reduced methylation capacity.
The direct biochemical result of these mutations is a bottleneck in the folate pathway. The MTHFR enzyme is less effective at its job of converting 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF). With less 5-MTHF available, the body can't efficiently convert homocysteine back into methionine. This can cause homocysteine to build up in the blood, a condition called hyperhomocysteinemia.
Prevalence Across Populations
The frequency of these MTHFR polymorphisms is not the same everywhere. It varies significantly across different ethnic and geographic populations. This variation is a fascinating glimpse into human genetic diversity.
| Population Group | C677T Homozygous (TT) Prevalence |
|---|---|
| Mediterranean Europeans | ~20-25% |
| North Americans (Caucasian) | ~10-15% |
| Hispanic | ~20-25% |
| East Asian | ~15-20% |
| Sub-Saharan African | ~1-2% |
For example, the C677T variant is relatively common in people of Hispanic and Mediterranean descent but is much rarer in individuals of African ancestry. The A1298C variant shows a different pattern, being more common in European populations. Understanding these population-specific frequencies is crucial for genetic research and public health, as it helps explain why the risk for certain related health conditions might differ between groups.